Download Prime Therapeutics and MDdatacor collaborate to improve patient

Contact:
Sheila Thelemann
Prime Therapeutics
Director, Corporate Communication
612.777.5508
[email protected]
Prime Therapeutics and MDdatacor collaborate to improve patient care
ST. PAUL, MINN. – Jan. 13, 2014 – In an effort to improve the quality and total cost of care for its members,
Prime Therapeutics LLC (Prime) has entered into a collaborative arrangement with MDdatacor, Inc. The
agreement will enable Prime to deliver enhanced drug therapy opportunities to health care professionals
enrolled in a pay-for-performance network.
Prime will use medical and pharmacy claims data to generate drug therapy opportunities from its
GuidedHealth℠ clinical rules platform. The information is then integrated into MDdatacor’s web-based
physician portal - MDinsight. Within MDinsight, the data from both platforms will be combined to provide
physicians with comprehensive, patient-centered data.
The portal will prompt physicians to work with specific patients regarding patient specific drug therapy
management opportunities. Examples include but are not limited to the following:
 Identifying opportunities to manage pharmacy underutilization. This would include the
identification of high risk members based on specific chronic conditions that are either not adhering
to prescribed drug therapy or need additional drug therapy (i.e., gap in care). The drug therapy
opportunity would not only alert the applicable physician to the adherence issue, it would provide a
historical set of data such as the proportion of days covered along with claim history for an individual
patient.
 Identifying members with a history of overutilization. This would include utilization patterns that
point to potential misuse or abuse of controlled substances, patterns of off-label indications,
polypharmacy and/or excessive duration of therapy.
 Identifying members with potential safety concerns such as direct medical contraindications to drug
therapy (i.e., FDA MedWatch program).
 Identifying opportunities for the member to save money by providing generic and/or preferred drug
alternatives.
“We are excited about the opportunity to enhance the delivery of critical drug therapy information at the point
of care,” said David Lassen, chief clinical officer at Prime Therapeutics.
This sharing of data helps improve care coordination, which will help result in better patient care.
“Providing accurate and timely medication use and adherence information to clinicians at the point of care
will greatly improve patient compliance with treatment and result in improved clinical outcomes and lower
healthcare cost to all,” said David Hanekom, chief medical officer at MDdatacor, Inc.
About MDdatacor
MDdatacor enhances health care quality through the development of innovative technology solutions.
MDdatacor's patented system is used to support quality improvement, health information exchange, clinical
integration and patient-centered medical home initiatives. MDdatacor currently serves more than 7,000
physicians representing more than seven million patients, and supports programs for clients such as
Wellmark Blue Cross and Blue Shield, Blue Cross Blue Shield of North Dakota, Blue Cross and Blue Shield of
Nebraska, CareFirst BlueCross BlueShield, Excellus BlueCross BlueShield, MVP Health Care, and Summa
Health Network.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime
manages pharmacy benefits for health plans, employers, and government programs including Medicare and
Medicaid. The company processes claims and delivers medicine to members, offering clinical services for
people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 25 million
people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.
Prime has been recognized by Modern Healthcare as one of “healthcare’s hottest companies for 2013.”
For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.
###